Booth Richard Douglas's Form 4 filing
Definitive Healthcare Corp.DH · filed Mar 7, 2022
- Accession no.
- 0000899243-22-009661
- Filed
- Mar 7, 2022
- Trade date
- Mar 3, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $50.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Booth Richard DouglasCIK 0001641054 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2022 | Class A common stock | PPurchaseAcquired | +2,374.17 | $21.06F2 | +$50,000.02 | 63,948.17 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Purchase prices range from $21.015 to $21.06 per share, inclusive.
Referenced by the price of 1 transaction in Table I.